Pharmaids Pharmaceuticals Limited (PHARMAIDS PHARMACEUTICALS LTD.) Aktie
PHARMAID.BO
GeschlossenPHARMAIDS PHARMACEUTICALS LTD.
Market Cap
$974,097,024
Über Pharmaids Pharmaceuticals Limited (PHARMAIDS PHARMACEUTICALS LTD.) Aktie
Pharmaids Pharmaceuticals Limited, together with its subsidiaries, provides contract research and manufacturing services for pharma, biotech, agro, and chemical industries in India. The company offers pharma intermediates, such as Dichloro Benzoyl nitrile, hydrazine carboximidamide 2 methane, pyridine carbonitrile,pyridine carboxylic acid, 8-chloro-10, 11-dihydro-4-aza-5H-dibenzo cycloheptene-5-one, 8-chloro-6,11-dihydro-11 cyclohepta pyridine,2-amino-5-methylthiopene-3-carbonitrile, 5-methyl-2-amino]thiophene-3-carbonitrile, 4-amino-2-methyl-10h-thiene benzodiazepine hydrochloride, 2,4-diamino-6-chloropyrimidine, hydronopol, squalene, 5-chloro-3-phenylanthranil, 2-amino-2,5-dichlorobenzophenone, 6-fluoro-3-4-piperidinyl-1,2-benzisoxazole hcl, 3-2-methyl-4H-pyrido pyrimidin-4-one, 4-n-hexyl resorcinol, triazole kopoxil, CAB-60, CABER-4, CAB-70, DTV, and avobenzone. It also provides active pharmaceuticals ingredients, including voglibose, silodosin, vitamin K2-7, UDCA, P5P, fluralaner, afoxolaner, maropitant, grapiprant, firocoxib, carprofen, loratadine, desloratadine, lamotrigine, gliclazide, and minoxidil. Pharmaids Pharmaceuticals Limited was incorporated in 1989 and is based in Bengaluru, India.
Unternehmensinformationen
560013 Bengaluru, India
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.